Lv1
30 积分 2023-09-21 加入
Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse
3天前
已完结
Iron overload exacerbates metabolic dysfunction-associated steatohepatitis via the microbiota-gut-liver axis through lipopolysaccharide-mediated Akr1b8 activation
3天前
已完结
Ferroptosis contribute to hepatic stellate cell activation and liver fibrogenesis
6天前
已完结
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
2个月前
已完结
Serum aldo–keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis
2个月前
已完结
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal
3个月前
已完结
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
3个月前
已完结
Head-to-head comparison of MASH resolution index versus FAST for noninvasive prediction of resolution of MASH on biopsy
3个月前
已完结
Aldo-keto Reductase 1B10 (AKR1B10) Suppresses Sensitivity of Ferroptosis in TNBC by Activating the AKT/GSK3β/Nrf2/GPX4 Axis
7个月前
已完结
Liver fibrosis in vitro: Cell culture models and precision-cut liver slices
7个月前
已完结
皖公网安备34019202002308
